Advertisement

Pharmacy World and Science

, Volume 25, Issue 4, pp 162–167 | Cite as

Leading ordinary lives: a qualitative study of younger women's perceived functions of antidepressants

  • P. Knudsen
  • E.H. Hansen
  • K. Eskildsen
Article

Abstract

Background: While the overall consumption of psychotropic medicines such as tranquillisers and hypnotics has declined, the consumption of the newer antidepressants – selective serotonin reuptake inhibitors (SSRIs) has increased drastically since their introduction. In order to understand the mechanisms underlying the use, it is important to gain insight into the users' perceptions about their medicine and use.Objective: To analyse younger women's perceived functions of SSRIs in their everyday lives. Methods: 12 in‐ depth interviews and 6 re‐ interviews were conducted with a community‐ based sample of 21‐ to 34‐ year‐ old women taking SSRIs. The women were recruited through Danish pharmacies.Results: Prior to taking SSRIs the women struggled with their emotional problems, often in great frustration and distress. While taking SSRIs the women experienced that the medicine functioned both at a psychological and a social level. They believed that the medicine gave them resources to behave actively in a way that was not previously possible. They felt that the medicine use enabled them to concentrate on daily life activities other than dealing solely with their emotional problems. The women found that the medicine gave them back a sense of 'normality'.Conclusion: The main finding in this paper is that the perceived functions of SSRIs were related to social meanings and goals in everyday life.

Denmark Function of medicine Lay perceptions SSRI‐antidepressants User perspective Women 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barry CA, Stevenson FA, Britten N, Barber N, Bradley CP. Giving voice to the lifeworld. More humane, more effective medical care? A qualitative study of doctor-patient communication in general practice. Soc Sci Med 2001; 53: 487–505.Google Scholar
  2. 2.
    Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997; 44: 681–92.Google Scholar
  3. 3.
    Almarsdóttir AB, Morgall JM. Technicians or patient advocates? - still a valid question. Pharm World Sci 1999; 21: 127–31.Google Scholar
  4. 4.
    Hansen EH, Launsø L. Drugs and users - problems and new directions. Health Promot 1988; 3: 241–8.Google Scholar
  5. 5.
    Danish Medicines Agency. Lægemiddelstatistik 1996–2000. [Drug statistics 1996–2000.]. Retrieved from: http://www. medicinpriser.dk/docushare/dscgi/ds.py/View/Collection-183 on 3 July 2002.Google Scholar
  6. 6.
    National Agency for Medicines and Social Insurance Institution. Finnish Statistics on Medicines 1999. Helsinki: National Agency for Medicines and Social Insurance Institution, 2000.Google Scholar
  7. 7.
    Swedish National Board of Health and Welfare. Läkemedel i användning - förändring och tendenser. Kvartalsrapport 2000: 1 Artikelnummer: 2000–77–021. [Drug applications - changes and trends. Quarterly report: 1. Article number: 2000–77–021.] Retrieved from http://www. sos.se/FULLTEXT/0077–012/0077–012.htm on 5 January 2001.Google Scholar
  8. 8.
    Gabe J, Lipshitz-Phillips S. Tranquillisers as social control? Sociol Rev 1984; 32: 524–46.Google Scholar
  9. 9.
    Helman CG. 'Tonic', ‘fuel’ and ‘food’: social and symbolic aspects of the long-term use of psychotropic drugs. Soc Sci Med 1981; 15B: 521–33.Google Scholar
  10. 10.
    Karp DA. Taking anti-depressant medications: resistance, trial commitment, conversion, disenchantment. Qual Soc 1993; 16: 337–59.Google Scholar
  11. 11.
    Knudsen P, Hansen EH, Morgall TJ, Eskildsen K. Changes in self-concept while using SSRI antidepressants. Qual Health Res 2002; 12: 928–40.Google Scholar
  12. 12.
    Hansen EH. How widely do women and men differ in their use of psychotropic drugs? A review of Danish studies. J Soc Adm Pharm 1989; 6: 165–83.Google Scholar
  13. 13.
    Hansen EH. Sovemedicin og nervemedicin - brug, afhængighed, intervention. [Hypnotics and tranquillisers - use, dependency and intervention.] The Danish Medicines Agency. Copenhagen: Schultz, 1997.Google Scholar
  14. 14.
    Graham K, Vidal-Zeballos D. Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985–1991): the relationship with gender, age and use of other substances. Soc Sci Med 1998; 46: 381–95.Google Scholar
  15. 15.
    Taylor SJ, Bogdan R. Introduction to qualitative research methods. A guidebook and resource, 3rd ed. New York: John Wiley & Sons, 1998.Google Scholar
  16. 16.
    Strauss A, Corbin J. Basics of qualitative research. Grounded theory procedures and techniques. Newbury Park, California: Sage Publications, 1990.Google Scholar
  17. 17.
    Mays N, Pope C. Assessing quality in qualitative research. BMJ 2000; 320: 50–3.Google Scholar
  18. 18.
    Green J, Britten N. Qualitative research and evidence based medicine. BMJ 1998; 316: 1230–2.Google Scholar
  19. 19.
    North D, Davis P, Powell A. Patient responses to benzodiazepine medication: a typology of adaptive repertoires developed by long-term users. Soc Health Illn 1995; 17: 632–50.Google Scholar
  20. 20.
    Larsen BO, Hansen EH. The active medicine user. Scand J Prim Health Care 1985; 3: 55–9.Google Scholar
  21. 21.
    Conrad P. The meaning of medication: Another look at compliance. Soc Sci Med 1985; 20: 29–37.Google Scholar
  22. 22.
    Knudsen P, Hansen EH, Traulsen JM. Perceptions of young women using SSRI antidepressants - a reclassification of stigma. Int J Pharm Pract 2002; 10: 243–52.Google Scholar
  23. 23.
    Miller RL. Researching life stories and family stories. London: Sage Publications, 2000.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • P. Knudsen
    • 1
  • E.H. Hansen
    • 1
  • K. Eskildsen
    • 1
  1. 1.Department of Social Pharmacy and FKL‐ Research Centre for Quality in Medicine UseThe Danish University of Pharmaceutical Sciences, Universitetsparken 2CopenhagenDenmark E‐mail

Personalised recommendations